Latest News and Press Releases

  Ad hoc announcement pursuant to Article 53 of the Six ExchangeRegulation Listing Rules     Lausanne, 4 May 2023 Q1 2023: Growth of adjusted revenue of 13.0% to CHF 290.5m, at constant...

The Institute of Human Biology aims to better predict which drug candidates are safe and most effective in patients by evolving and increasing the use of human model systems. Human model systems are...

Media relations:Victoire GruxTel.: +33 6 04 52 16 55victoire.grux@capgemini.com Investor relations:Vincent BiraudTel.: +33 1 47 54 50 87vincent.biraud@capgemini.com Capgemini reports Q1 2023 growth...

INSIDE INFORMATION International patent to allow the development of an industrial biomarker analysis kit which could generate a turnover of 30 to 40 million euros globally Mont-Saint-Guibert,...

Geneva, Switzerland, May 4, 2023 – Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today...

ENEDO PLC   Business Review May 4th, 2023 at 8:00 Enedo Plc Publishes Business review January 1 – March 31, 2023 - Positive net profit enabled by strong orderbook and improvements in logistics ...

                                                                May 4, 2023 at 7 a.m. CET Solvay first quarter 2023 resultsStrong pricing drives +22% organic EBITDA growth in the quarterUpgraded...

Product sales increased 98.6% to €32.1 million in the first quarter of 2023 compared to €16.2 million in the first quarter of 2022 Driven by IXIARO® and DUKORAL® sales both of which more than...

Sievi Capital PlcStock Exchange Release 4 May 2023 at 8:00 am EEST Sievi Capital Plc’s Business Review for January–March 2023 Focus on operational efficiency and preparation for strategy...

Double-digit year-on-year revenue growth;Adjusted EBITDA doubling versus Q1 2022, with margin at 9%, up year on year and quarter on quarter;Leverage ratio reduced to 5.3x, fueled by EBITDA...